UBS
http://www.ubs.com/UBS provides a range of financial services, including advisory services, underwriting, financing, market making, asset management, brokerage and retail banking on a global level. The Company consists of four divisions: Wealth Management, Asset Management, Investment Banking & Security and Swiss Retail & Corporate Banking. Wealth Management offers high net worth customers advice and investment services, Asset Management offers management solutions for most types of asset class to a range of clients, Investment Banking & Security provides securities, products and research in various areas equities and Swiss Retail & Corporate Banking offers banking and securities services for Swiss clients.
-
-
-
-
-
-
-
UBS Reiterates Neutral Rating on GlaxoSmithKline (GSK)
-
-
-
-
-
-
-
U.S.-China trade truce triggers European share surge
-
-
-
-
-
-
-
UBS Upgrades GlaxoSmithKline (GSK) to Buy
-
-
-
-
-
-
-
UBS Upgrades GlaxoSmithKline (GSK) to Buy
-
-
-
-
-
-
-
UBS Downgrades GlaxoSmithKline (GSK) to Neutral
-
-
-
-
-
-
-
Notable Analyst Rating Changes 02/26: RST, AZN/GSK, CHA/CHU, OSIS, LAMR Upgraded; PALM, DPS, ATHN, FLR, MOT Downgraded
-
-
-
-
-
-
-
Trading Radar for 4/22: Apple (AAPL), Wells Fargo (WFC), Morgan Stanley (MS), Boeing (BA), eBay (EBAY), AT&T (T), McDonald's (MCD), GlaxoSmithKline (GSK), Freeport McMoRan (FCX), Altria (MO) Report
-
169,749 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

